Point-of-care diagnostics are reshaping how and where patients access healthcare. However, challenges around enzyme stabilization, cost, and logistics can limit their reach.

Speaker: William Ferreira, R&D Team Leader at Meridian Life Science

Learn more about our solutions for:

• Molecular point-of-care testing (qPCR, isothermal amplification, and next-generation sequencing)
• Ambient-stable reagent chemistries (lyophilization, cold-chain free)
• Infectious disease diagnostics
• Decentralized testing & rapid assay development
• Scalability in resource-limited or near-patient settings

Discover how Meridian’s technologies support the development of assays suitable for clinical labs, pharmacies, and at-home use.